Events, By Category and Date:
» Go to news mainCRISPR‑Cas9 and the Theo‑Ethics of Gene Editing
A Panel-Guided Ethical and Theological Dialogue
The purpose of this event is to assist participants in thinking theologically and ethically about how gene-editing technology (esp. CRISPR) is challenging our understanding of what it means to be human, and how humans act as stewards of God’s creation.
In the past 10 years, CRISPR technology has made a reality of human gene editing as well as creating novel genetically modified plants and animals. Applications include human health, human enhancement, food source enhancement, pest elimination, and the creation of innovative biological weapons. Using both an ethical and theological lens, our panel will guide our conversation on the potential risks and benefits of this new technology.
Panel Participants
• Dr. Francoise Baylis, University Research Professor, Dalhousie University
• Dr. Moira McQueen, Executive Director, Canadian Catholic Bioethics Institute
• Rev. Dr. Tracy Trothen, Professor of Ethics, Queen’s University
• Michael Buttrey, doctoral candidate in Christian Ethics, Regis College
REGISTRATION https://bit.ly/3Dksgo9
FOR MORE INFORMATION Contact Rev. Dr. Peter Kuhnert peterkuhnertcan@aol.com
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize